- Medical/Professional School:
-
Harvard Medical School, Boston
University of Washington, Seattle
- Clinical Interests:
-
Early lung disease in cystic fibrosis, Cystic fibrosis epidemiology
- Description of Research:
-
Clinical and epidemiologic research in cystic fibrosis (CF), emphasizing early CF lung disease. Development of outcome measures for clinical trials in young CF patients, including infant and preschool lung function tests.
- Key Publications:
-
Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatric Pulmonology. 2001;32:356-366.
Rosenfeld M, Gibson R, McNamara S, Emerson J, McCoy K, Shell R, Borowitz D, Konstan M, Retsch-Bogart G, Wilmott RW, Burns JL, Vicini P, Montgomery B, Ramsey B. Serum and lower respiratory tract drug concentrations produced by tobramycin for inhalation in young children with cystic fibrosis. Journal of Pediatrics. 2001;139(4):572-7.
Kulich M., Rosenfeld M., Goss CH, and Wilmott R.. Improved survival among young patients with cystic fibrosis. Journal of Pediatrics. 2003:142(6);631-636.
Rosenfeld M, Gibson R, Ramsey BW. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Current Opinions in Pulmonary Medicine. 2003 Nov;9(6):492-7.
Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: Evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR. 2004;53 (No. RR-13):1-35. Prepared by Grosse DS, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS.